The decreased expression of rRNA in CD34+ cells from patients with myelodysplastic syndromes may reduce the synthesis of ribosomal proteins leading to defective hematopoiesis and bone marrow failure (Raval et al., 2012). The gene discussed is CD34; the disease is myelodysplastic syndrome.